Long-Standing SITC Member, James P. Allison, PhD, Wins Prestigious Lasker Award
James P. Allison, PhD, will receive the nation’s highest honor in clinical medical research for the discovery and development of a monoclonal antibody therapy. The therapy unleashes the immune system to recognize and attack cancer. This discovery—known as checkpoint blockade—has resulted in new cancer treatments, including immunotherapy for metastatic melanoma that has been shown to extend patients’ lives by as much as a decade.
Dr. Allison will be discussing his journey in the field during the keynote Milestones in Immunotherapy session at SITC’s 30th Anniversary Annual Meeting on Friday, November 6. A long-standing SITC member, Dr. Allison served as an At-Large Director in early 2000 and was the 2010 recipient of SITC’s Richard V. Smalley, MD Memorial Award for his contributions to cancer immunotherapy research.
About the Lasker-DeBakey Awards
Known as the “American Nobels,” the Lasker-DeBakey Awards recognize scientists whose discoveries have improved the clinical treatment of patients. Other 2015 Lasker-DeBakey Award winners include Evelyn M. Witkin and Stephen J. Elledge for discoveries concerning the DNA-damage response, as well as Médecins Sans Frontieres (Doctors without Borders) for bold leadership in responding to the recent Ebola outbreak in Africa and for sustained and effective frontline responses to health emergencies.
We congratulate Dr. Allison on his exceptional achievement!